$42.30
+0.02 (+0.05%)
Performance
1D
—
1W
—
1M
—
3M
+4.34%
6M
+49.42%
1Y
+168.57%
YTD
+34.71%
Open$42.04
Previous Close$42.28
Day High$42.94
Day Low$41.06
52W High$46.67
52W Low$11.85
Volume—
Avg Volume841.9K
Market Cap3.73B
P/E Ratio—
EPS$-0.81
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.31
Above
SMA 200
$25.48
Above
RSI (14)
31.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+2.1% upside
Current
$42.30
$42.30
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 162.03M | 12.24M | 783.80M |
| Net Income | -70,537,483 | -102,665,771 | 150.56M |
| Profit Margin | -43.5% | -885.1% | 19.2% |
| EBITDA | -52,553,023 | -104,281,125 | 266.89M |
| Free Cash Flow | — | — | 76.52M |
| Rev Growth | +115.0% | +2.9% | +0.6% |
| Debt/Equity | 1.49 | 1.49 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |